Concepedia

David Aviezer

DA

Statistics

Publications

30

Citations

3K

H-Index

23

Active since

1993

Affiliations

Weizmann Institute of Science(Current)

Protalix BioTherapeutics (Israel)

Shaare Zedek Medical Center

Bar-Ilan University

Assaf Harofeh Medical Center

David Aviezer is an author at Weizmann Institute of Science specializing in life sciences, biochemistry, and growth factor signaling.

Publications per year

1993–2015

30

Publications

30

Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis

David Aviezer, Dalit Hecht, Michal Safran et al. · Cell · 1994 · 535 citations

, , +9

Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system

Yoseph Shaaltiel, Daniel Bartfeld, Sharon Hashmueli et al. · Plant Biotechnology Journal · 2007 · 429 citations · Full text

, , +17

Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor.

David Aviezer, Ehud Levy, Michal Safran et al. · Journal of Biological Chemistry · 1994 · 254 citations · Full text

, , +17

Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease

Ari Zimran, Einat Brill‐Almon, Raul Chertkoff et al. · Blood · 2011 · 205 citations · Full text

, , +13

A Plant-Derived Recombinant Human Glucocerebrosidase Enzyme—A Preclinical and Phase I Investigation

David Aviezer, Einat Brill‐Almon, Yoseph Shaaltiel et al. · PLoS ONE · 2009 · 185 citations · Full text

, , +17

1–5 of 30